Men show a higher mortality than women, especially at a young age (between 15 and 39 years). They are more likely to engage in unhealthy behaviours and tend not to implement preventative efforts or to seek help. While (mental) health promotion programmes aim to foster healthy behaviours, men often do not feel addressed by them and are therefore reluctant to participate. This synthesis aims at drawing together barriers to and facilitators of male participation in (mental) health promotion programmes and identifying how to best address men in health communication and programme promotion.

This rapid qualitative evidence synthesis includes a sample of 21 studies. 18 are qualitative studies and 3 are mixed-methods studies with separately reported qualitative findings that captured the perspectives of males aged 12 to 79 years and of professionals working in men's health on the barriers to and facilitators of participation in (mental) health promotion programmes and on preferred health communication. Studies were purposefully selected to maximise variation across interview content, context, and participant characteristics (e.g., age, occupation). The selection was restricted to studies published between 2015 and 2025.

Gender norms were one of the main barriers to participation in men's (mental) health promotion programmes. Preferably such programmes should be integrated into settings attractive or familiar to men, such as sport clubs or handicraft workshops, or the workplace. Peers and peer support played a crucial role within men's health promotion and were found to facilitate positive behavioural changes. When reaching out to men, clinical and stigmatising terminology should be avoided in favour of action-oriented language that emphasises control and practical solutions while keeping the messaging simple and focused on tangible benefits.

Health promotion programmes for men require embedding interventions within male-relevant contexts, such as sports, workplaces, and peer networks, that ease participation and reduce stigma. To reach and benefit men, communication strategies should use relatable, non-stigmatising language from credible messengers and should frame self-care as compatible with masculine identities.

Digital mental health tools-including telehealth, mobile applications, wearable devices, machine learning, and artificial intelligence-are changing the way patients and providers manage mental health care. This review summarizes the current research findings of digital interventions on patient access to care, the factors impacting personalized care, and overall patient engagement. Gaps of knowledge and future considerations are discussed, including careful observation of existing barriers to care. Clinical recommendations are discussed for clinicians who are considering implementing digital mental health tools into practice.

This article presents a review of examples of digital mental health technology (DMHT) for assessing and treating posttraumatic stress disorder (PTSD), including research supporting these innovative solutions. Tools for assessing PTSD are reviewed, including digital administration of self-report measures, ecological momentary assessment methods, personal sensing, electronic medical record and other naturalistic data sources, and emerging digital assessment tools. Next, DMHTs for PTSD treatment are reviewed, including Internet-based interventions, mobile mental health apps, virtual reality therapy, and several emerging digital interventions. DMHT applications for PTSD have demonstrated promise in research and are beginning to be used in clinical practice.

Obsessive-compulsive disorder (OCD) is a debilitating neuropsychiatric disorder that remains chronic unless intervened with evidence-based intervention. Cognitive behavioral therapy (CBT) with exposure and response prevention is the gold-standard psychological intervention for OCD, but many individuals do not receive this intervention due to barriers to accessing treatment. Mental health technology tools such as telehealth, computerized programs, internet-delivered CBT, and mobile applications have been adopted to expand the accessibility of CBT. An up-to-date summary of the evidence base of technology-mediated formats of CBT for OCD treatment is provided. Clinical benefits offered by such approaches, current limitations, and future research directions are discussed.

Depression leads to a significant societal burden worldwide, yet most individuals affected lack adequate care. Digital mental health treatments (DMHTs) offer evidence-based, accessible interventions via websites, text messaging, virtual reality, and mobile apps, among other technologies. Studies demonstrate DMHT effectiveness, often comparable to traditional therapies, with high treatment acceptability and satisfaction. Key challenges include poor engagement, high attrition, and limited integration into routine care. Despite these barriers, innovations such as human support, improved reimbursement practices, patient-treatment matching strategies, and emerging AI-driven tools promise to broaden DMHTs' impact and position these programs as a frontline treatment option for depression globally.

Anxiety disorders can emerge across the lifespan, causing significant distress and impairment. Although evidence-based treatments like cognitive behavioral therapy exist for anxiety disorders, several challenges exist when implementing these treatments in clinical practice that can impede treatment accessibility and/or effectiveness. Fortunately, several technological advancements have resulted in considerable innovative solutions. Here, we examine the evidence for augmenting evidence-based treatments for anxiety disorders using: (1) telehealth/telemedicine; (2) digital mental health interventions and mobile health applications; and (3) virtual reality, extended reality, and/or augmented reality. Despite the considerable promise of technological augmentation of evidence-based treatment, further research and technological advancements are needed.

Wearable technology holds promise for improving mental health care by enabling continuous, objective monitoring of physiologic parameters. Building on decades of psychophysiology research, wearables can provide an additional source of measurement for implementing measurement-based care in learning mental health systems. This review describes wearable use across inpatient and outpatient settings, identifying gaps and opportunities in clinical care and research. While widely studied in outpatient, wearables hold immense potential for in inpatient settings. Advancements needed include user-centered design, better understanding of complex populations and settings, and use of modern analytical methods to generate clinically actionable mental health insights for all.

Digital phenotyping-the moment-by-moment quantification of human behavior using data from smartphones and wearables-offers new pathways for mental health research and care. This review summarizes current trends, tools, and applications of digital phenotyping, highlighting its growing clinical relevance in early detection, symptom monitoring, and personalized interventions. Although studies increasingly demonstrate its feasibility and clinical utility across conditions such as depression, anxiety, and schizophrenia, challenges persist. These challenges include inconsistent data quality, small and nonrepresentative samples, lack of methodological standardization, and pressing ethical considerations about privacy and transparency.

Over the past decade, telehealth-delivered psychotherapy has become an increasingly accessible and viable modality for providing evidence-based care. Current research on its efficacy is varied, with some protocols demonstrating comparable outcomes between virtual and in-person modalities and others suggesting a differential impact of disorder and/or protocol-specific factors (eg, symptom severity). This review examines recent findings across treatment settings and protocol types as well as provides recommendations and considerations for providers. Future research is warranted to further compare virtual and in-person treatment delivery and determine long-term outcomes.

This operative video report demonstrates two cases of endoscopic fenestration for enlarging symptomatic thalamic cysts causing obstructive hydrocephalus. A literature review of 29 cases (1987-2026)^1-17 reveals hydrocephalus present in the majority of cases. Common presentations include headache, gait disturbance, and cognitive changes. The first case involves a 62-year-old female with progressive proprioceptive deficits and imbalance due to a 2.5 cm right thalamic cyst protruding into the third ventricle. The second case involves a 59-year-old female presenting with altered mental status and headaches from an enlarging right thalamic cyst. In both cases, a frontal transcortical endoscopic approach was utilized to fenestrate the cysts into the lateral and third ventricles in combination with an endoscopic third ventriculostomy. To ensure precise access, two separate trajectories were employed: one providing a straight-line path to the cyst wall and another to the floor of the third ventricle. Fenestration was achieved using blunt dissection and Fogarty balloon dilation, followed by further enlargement with alligator clamps. Postoperatively, both patients experienced complete resolution of symptoms and mass effect. These cases illustrate that while benign thalamic neuroepithelial cysts are rarely symptomatic¹⁰, they can be effectively treated with endoscopic fenestration. While treatment approaches in the literature vary, endoscopic or microsurgical fenestration remains the most common intervention. This technique, utilizing a high-resolution rigid endoscope coupled with stereotactic navigation and preoperative trajectory planning, allows for safe and effective treatment of these deep cystic lesions.